Cell MedX Corp. Stock Other OTC
Equities
CMXC
US15115X1072
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 0.01 | Sales 2023 | 0 | Capitalization | 6.29K |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 1,135,153,669 x |
Net Debt 2022 | 592K | Net Debt 2023 | 903K | EV / Sales 2023 | 329,116,944 x |
P/E ratio 2022 |
-9.01
x | P/E ratio 2023 |
-0.01
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.34% |
Managers | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | Dec. 11 |
Yanika Silina
DFI | Director of Finance/CFO | 45 | 14-11-23 |
George Adams
CHM | Chairman | 76 | 18-03-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Jeffs
CEO | Chief Executive Officer | 54 | Dec. 11 |
Dwayne Yaretz
BRD | Director/Board Member | 63 | 22-04-26 |
Joao da Costa
BRD | Director/Board Member | 59 | 20-06-07 |
1st Jan change | Capi. | |
---|---|---|
-1.42% | 41.35B | |
+42.15% | 40.38B | |
+1.97% | 39.05B | |
-14.19% | 26.67B | |
+1.82% | 24.07B | |
-24.55% | 18.36B | |
-4.07% | 11.68B | |
+21.36% | 11.6B | |
+8.20% | 11.15B |